Found: 8
Select item for more details and to access through your institution.
Non-capsular based immunization approaches to prevent Streptococcus pneumoniae infection.
- Published in:
- Frontiers in Cellular & Infection Microbiology, 2022, v. 12, p. 1, doi. 10.3389/fcimb.2022.949469
- By:
- Publication type:
- Article
Safety and Immunogenicity of an Inactivated Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine in a Subgroup of Healthy Adults in Chile.
- Published in:
- Clinical Infectious Diseases, 2022, v. 75, n. 1, p. e792, doi. 10.1093/cid/ciab823
- By:
- Publication type:
- Article
Differential Severe Acute Respiratory Syndrome Coronavirus 2–Specific Humoral Response in Inactivated Virus–Vaccinated, Convalescent, and Breakthrough-Infected Subjects.
- Published in:
- Journal of Infectious Diseases, 2023, v. 228, n. 7, p. 857, doi. 10.1093/infdis/jiad320
- By:
- Publication type:
- Article
Cytokines in the Respiratory Airway as Biomarkers of Severity and Prognosis for Respiratory Syncytial Virus Infection: An Update.
- Published in:
- Frontiers in Immunology, 2019, p. N.PAG, doi. 10.3389/fimmu.2019.01154
- By:
- Publication type:
- Article
Identification of biomarkers for disease severity in nasopharyngeal secretions of infants with upper or lower respiratory tract viral infections.
- Published in:
- Clinical & Experimental Immunology, 2022, v. 210, n. 1, p. 68, doi. 10.1093/cei/uxac083
- By:
- Publication type:
- Article
Characterization of the humoral and cellular immunity induced by a recombinant BCG vaccine for the respiratory syncytial virus in healthy adults.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1215893
- By:
- Publication type:
- Article
Recognition of Variants of Concern by Antibodies and T Cells Induced by a SARS-CoV-2 Inactivated Vaccine.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.747830
- By:
- Publication type:
- Article
Immune Profile and Clinical Outcome of Breakthrough Cases After Vaccination With an Inactivated SARS-CoV-2 Vaccine.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.742914
- By:
- Publication type:
- Article